About US
Contact us
-
FDA approves first new influenza treatment in two decadesThe US Food and Drug Administration (FDA) has granted approval of Xofluza (baloxavir marboxil) to Japanese pharmaceutical company Shionogi for the treatment of acute uncomplicated influenza (flu). Sa2018/10/25
-
MPs told public may need to stockpile drugs in no-deal BrexitThe UK pharmaceutical industry bodies have told MPs that patients may need to stockpile their own drugs in case of a no-deal Brexit, which could result in ‘catastrophic consequences’ for drug supply.2018/10/25
-
Merck KGaA opens $72M distribution facility at German headquartersMerck KGaA has opened a new distribution center as it continues to streamline its manufacturing and build up the production site at its headquarters in Darmstadt, Germany. The €63 million ($72.3 mill2018/10/24
-
GlaxoSmithKline expands API production for COPD inhalers as Advair sales witherEven with looming generic competition expected to take a big bite out of sales of its blockbuster Advair, respiratory drugs remain key to GlaxoSmithKline, and itcontinues to plow money into their prod2018/10/24
-
Sanofi's Dupixent set for $2.5B in peak asthma sales after scoring winning label: analystEven as its diabetes unit struggles, Sanofi has made strides on the market with Dupixent since launching last year in eczema. Now, with an FDAapproval(PDF) late Friday in asthma, one analyst believes2018/10/23
-
Consumer deal fever hits Johnson & Johnson with $2.1B deal to buy out Japan's Ci:zAdd another Big Pharma company to the wheeling and dealing inconsumer health: Johnson & Johnson is shelling out to take full control of Japanese cosmetics and skincare specialist Ci:z. J&J pl2018/10/23
-
Changsheng Bio-Technology fined $1.3bn after vaccine scandalsA Chinese drug watchdog has imposed a fine and asset seizure worth CNY9.1bn ($1.3bn) on Changsheng Bio-Technology following two major vaccine scandals. This amount includes a confiscation of the comp2018/10/22
-
Takeda gets Japanese approval for $62bn Shire acquisitionTakeda Pharmaceutical is close to completing the $62bn acquisition of Irish biopharmaceutical company Shire after receiving approval from the Japan Fair Trade Commission. The company agreedto acquire2018/10/22
-
Even in worst-case scenario, Roche will grow past biosimilar erosion in the U.S.: executiveRoche’s trio of megablockbuster cancer drugs, Herceptin, Rituxan and Avastin, still held their groundin the third quarter, despite a biosimilar onslaught in Europe. And though next year will be a diff2018/10/19
-
Amgen, Lilly migraine drugs nab Express Scripts backing, but Teva's shut outEarly into their hotly anticipated migraine launches, Amgen and Eli Lilly have picked up key coverage from Express Scripts, but Teva's Ajovy was left out in the cold. Express Scripts chose to cov2018/10/19